Health
Johnson & Johnson vaccine shows strong neutralisation on COVID Delta variant, says company – Republic World
Johnson & Johnson’s COVID vaccine (Janssen) has generated strong, persistent activity against the rapidly spreading Delta variant…
In a boost for one-shot Johnson & Johnson’s COVID vaccine (Janssen), the company announced on Thursday, that its vaccine generated strong, persistent activity against the rapidly spreading Delta variant and other highly prevalent COVID variants. The eight-month-long…
Continue Reading
-
Business15 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business19 hours agoThis leading broker thinks the CSL share price can climb 40%
-
Business12 hours agoDicker Data rides the AI trend to double digit growth
-
Business15 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy